Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |